CRP and myocardial infarction: The investigators of the recently published “CRP apheresis in Acute Myocardial Infarction (CAMI-1)” study moved downstream of IL-6 in the inflammatory cascade, directly targeting the inflammatory marker high-sensitivity C-reactive protein (hsCRP) (16).